Global Immunohematology Market Size study, by Product (Immunohematology analyzer, Immunohematology reagent), by End-User (Hospitals, Blood Banks, Diagnostic Laboratories) and Regional Forecasts 2020-2027

  • Product Code:
    RP-ID-10346975
  • Published Date:
    1 Apr 2021
  • Region:
    Global
  • Pages:
    200
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-14

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

Market Overview:

Global Immunohematology Market is valued approximately at USD 2.0 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.6% over the forecast period 2020-2027. Immunohematology is a division of hematology and transfusion medicine that studies antigen-antibody reactions and analogous phenomena since they correlate to the pathogenesis and clinical indications of blood disorders. Immunohematology helps in the diagnosis of blood antigens, white blood cell, Rh factor, and plasma components in the donor blood. It is commonly known as blood banking, that deals with creation of blood elements for transfusion. It often facilitates in reduction of transfusion-associated fatalities, such as HIV and thalassemia. Moreover, the advent of next-generation immunohematology devices often helps clinicians to improve the effectiveness of emergency support to patients. It can lead to introduce more advanced features in immunohematology devices that can meet certain requirements of end-users. Therefore, this factor may drive the demand for immunohematology market.

Moreover, the rise in prevalence of HIV and other target diseases, along with increasing investment by public and private organization in blood banks are the few factors responsible for the CAGR of the market during the forecast period. According to the Joint United Nations Programme on HIV and AIDS (UNAIDS), in 2019, nearly 1.7 million individuals were newly affected by HIV, compared to a 2.8 million adult population in 1998. This, in turn, is likely to strengthen the demand for Immunohematology, thereby contributing to the market growth around the world. However, the high cost and lack of awareness regarding the product is one of the prime factors restraining the market growth over the forecast period of 2020-2027.

The regional analysis of the global Immunohematology market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising government support to for blood transfusion, along with the significant presence of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the increasing awareness concerning genetic testing for blood disorders coupled with growing prevalence of target diseases in the developing nations, such as China and India, are the few factors creating a lucrative opportunity for the growth of the Immunohematology market in the Asia-Pacific region.

Major market player included in this report are:
Bio-Rad Laboratories, Inc.
Immucor, Inc.
Grifols, S.A.
Becton, Dickinson and Company
Hologic, Inc.
Siemens Healthcare GmbH
Thermo Fisher Scientific
Abbott Laboratories
Beckman Coulter Inc.
Roche Diagnostics Corp.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Immunohematology analyzer
Immunohematology reagent

By End-User:
Hospitals
Blood Banks
Diagnostic Laboratories

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Immunohematology Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Immunohematology Market, by Region, 2018-2027 (USD Billion)
1.2.2. Immunohematology Market, by Product, 2018-2027 (USD Billion)
1.2.3. Immunohematology Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Immunohematology Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Immunohematology Market Dynamics
3.1. Immunohematology Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Immunohematology Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Immunohematology Market, by Product
5.1. Market Snapshot
5.2. Global Immunohematology Market by Product, Performance - Potential Analysis
5.3. Global Immunohematology Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
5.4. Immunohematology Market, Sub Segment Analysis
5.4.1. Immunohematology analyser
5.4.2. Immunohematology reagent
Chapter 6. Global Immunohematology Market, by End-User
6.1. Market Snapshot
6.2. Global Immunohematology Market by End-User, Performance - Potential Analysis
6.3. Global Immunohematology Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
6.4. Immunohematology Market, Sub Segment Analysis
6.4.1. Hospitals
6.4.2. Blood Banks
6.4.3. Diagnostic Laboratories
Chapter 7. Global Immunohematology Market, Regional Analysis
7.1. Immunohematology Market, Regional Market Snapshot
7.2. North America Immunohematology Market
7.2.1. U.S. Immunohematology Market
7.2.1.1. Product breakdown estimates & forecasts, 2017-2027
7.2.1.2. End-User breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Immunohematology Market
7.3. Europe Immunohematology Market Snapshot
7.3.1. U.K. Immunohematology Market
7.3.2. Germany Immunohematology Market
7.3.3. France Immunohematology Market
7.3.4. Spain Immunohematology Market
7.3.5. Italy Immunohematology Market
7.3.6. Rest of Europe Immunohematology Market
7.4. Asia-Pacific Immunohematology Market Snapshot
7.4.1. China Immunohematology Market
7.4.2. India Immunohematology Market
7.4.3. Japan Immunohematology Market
7.4.4. Australia Immunohematology Market
7.4.5. South Korea Immunohematology Market
7.4.6. Rest of Asia Pacific Immunohematology Market
7.5. Latin America Immunohematology Market Snapshot
7.5.1. Brazil Immunohematology Market
7.5.2. Mexico Immunohematology Market
7.6. Rest of The World Immunohematology Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Bio-Rad Laboratories, Inc.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Immucor, Inc.
8.2.3. Grifols, S.A.
8.2.4. Becton, Dickinson and Company
8.2.5. Hologic, Inc.
8.2.6. Siemens Healthcare GmbH
8.2.7. Thermo Fisher Scientific
8.2.8. Abbott Laboratories
8.2.9. Beckman Coulter Inc.
8.2.10. Roche Diagnostics Corp.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Bio-Rad Laboratories Inc.
Immucor, Inc.
Grifols, S.A.
Becton, Dickinson and Company
Hologic, Inc.
Siemens Healthcare GmbH
Thermo Fisher Scientific
Abbott Laboratories
Beckman Coulter Inc.
Roche Diagnostics Corp.

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports